Expanding Access to Healthcare
Through our core business – the discovery, development and marketing of innovative treatments – we have helped prevent and treat diseases, ease suffering and improve quality of life for people worldwide.
But as the size and complexity of the world’s healthcare challenges grow, we must widen our scope, extending our impact even further by asking: How can we effectively address the needs of underserved populations? How can we bring the benefits of our medicines to more people? And how can we do this in a way that is sustainable for our business?
It begins with a fundamental shift in the way we do business – with reimagining new ways to bridge the divide between those with access to critical healthcare innovations and those without.
We are committed to bringing more of our medicines to more people, no matter where they are. For all our new medicines, we will systematically integrate access strategies in how we research, develop and deliver globally. This will be a key measure of success for our leaders and employees.
In this section
- Novartis Access Principles
- We commit to bringing more of our medicines to more people, no matter where they are. For all our new medicines, we will systematically integrate access strategies in how we research, develop and deliver globally.
- Creating sustainable business models
- We believe scalable, self-sustaining social business approaches have the potential to better address global public health needs. Novartis has pioneered social business models like Healthy Family and Novartis Access.
- Novartis Oncology Access
- Novartis Oncology Access is a sustainable access solution which is designed to improve access in countries with very limited healthcare reimbursement systems.
- The Novartis Foundation
- The Novartis Foundation explores innovative solutions for public health challenges, with a goal of making a transformational impact on patients and communities.
- Sandoz
- Our generics division brings access to high-quality medicines, medical information and healthcare to millions of people every year.
- Patents and Licensing
- Novartis does not file or enforce patents in least developed countries (LDCs), and we take a flexible approach to patent filing in lower-middle income countries (LMICs).
- Donations
- We continue to engage in strategic donations to address access gaps for neglected diseases and people at the bottom of the pyramid.